Sunitinib and Changes in Right Ventricular Function: Insights From a Prospective Cohort of Patients With Metastatic Renal Cell Carcinoma

被引：0
|
作者：
Rethy, Leah
Demissei, Biniyam
Narayan, Vivek
Haas, Naomi
Ky, Bonnie
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13485
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Risk of left ventricular systolic dysfunction with sunitinib therapy in patients with metastatic renal cell carcinoma: A prospective cohort study.
    Narayan, Vivek
    Wang, Le
    Putt, Mary
    Keefe, Stephen Michael
    Hass, Naomi B.
    Lenihan, Daniel John
    Puzanov, Igor
    Catino, Anna
    Fang, James
    Ewer, Steven M.
    Moncher, Karen
    ElAmm, Chantal
    Oliveira, Guilherme
    Narayan, Hari
    Ky, Bonnie
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Sunitinib in patients with metastatic renal cell carcinoma
    Motzer, Robert J.
    Rini, Brian I.
    Bukowski, Ronald M.
    Curti, Brendan D.
    George, Daniel J.
    Hudes, Gary R.
    Redman, Bruce G.
    Margolin, Kim A.
    Merchan, Jaime R.
    Wilding, George
    Ginsberg, Michelle S.
    Bacik, Jennifer
    Kim, Sindy T.
    Baum, Charles M.
    Michaelson, M. Dror
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21): : 2516 - 2524
  • [3] Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma
    Catino, Anna B.
    Hubbard, Rebecca A.
    Chirinos, Julio A.
    Townsend, Ray
    Keefe, Stephen
    Haas, Naomi B.
    Puzanov, Igor
    Fang, James C.
    Agarwal, Neeraj
    Hyman, David
    Smith, Amanda M.
    Gordon, Mary
    Plappert, Theodore
    Englefield, Virginia
    Narayan, Vivek
    Ewer, Steven
    ElAmm, Chantal
    Lenihan, Daniel
    Ky, Bonnie
    CIRCULATION-HEART FAILURE, 2018, 11 (03) : e004408
  • [4] Do patients with metastatic renal cell carcinoma benefit from sunitinib?
    Bryan Y Wong
    Nicholas J Vogelzang
    Nature Clinical Practice Oncology, 2007, 4 : 72 - 73
  • [5] Do patients with metastatic renal cell carcinoma benefit from sunitinib?
    Wong, Bryan Y.
    Vogelzang, Nicholas J.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (02): : 72 - 73
  • [6] Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma
    Nachbargauer, Sebastian
    Bruchbacher, Andreas
    Fajkovic, Harun
    Remzi, Mesut
    Schmidinger, Manuela
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : E277 - E283
  • [7] SUNITINIB RECHALLANGE IN METASTATIC RENAL CELL CARCINOMA PATIENTS
    Nagyivanyi, K.
    Biro, K.
    Gyergyay, F.
    Kueronya, Z.
    Nemeth, H.
    Geczi, L.
    ANNALS OF ONCOLOGY, 2012, 23 : 281 - 281
  • [8] Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma Patients
    Zama, Ivan N.
    Hutson, Thomas E.
    Elson, Paul
    Cleary, James M.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    Ramaiya, Nikhil
    Michaelson, M. Dror
    Garcia, Jorge A.
    Knox, Jennifer J.
    Escudier, Bernard
    Rini, Brian I.
    CANCER, 2010, 116 (23) : 5400 - 5406
  • [9] Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma
    Narayan, Vivek
    Keefe, Stephen
    Haas, Naomi
    Wang, Le
    Puzanov, Igor
    Putt, Mary
    Catino, Anna
    Fang, James
    Agarwal, Neeraj
    Hyman, David
    Smith, Amanda M.
    Finkelman, Brian S.
    Narayan, Hari K.
    Ewer, Steven
    ElAmm, Chantal
    Lenihan, Daniel
    Ky, Bonnie
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3601 - 3609
  • [10] Renal safety of sunitinib treatment: A prospective study for patients (pts) with metastatic renal cell carcinoma (mRCC)
    Billemont, B.
    Rixe, O.
    Meric, J. B.
    Alexandre, J.
    Goldwasser, F.
    Izzedine, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 36 - 36
12345